WINTON GROUP Ltd Invests $14.14 Million in Humana Inc. $HUM

Posted by Brenda Bartman on Sep 10th, 2026

WINTON GROUP Ltd purchased a new position in shares of Humana Inc. (NYSE:HUM – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 35,602 shares of the insurance provider’s stock, valued at approximately $14,142,000.

Several other large investors have also recently added to or reduced their stakes in the company. Manning & Napier Advisors LLC bought a new stake in Humana in the 2nd quarter valued at about $1,412,000. Sustainable Insight Capital Management LLC grew its position in shares of Humana by 23.7% during the 4th quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock worth $6,341,000 after purchasing an additional 4,740 shares in the last quarter. Pzena Investment Management LLC bought a new position in shares of Humana during the second quarter worth approximately $1,749,014,000. North Dakota State Investment Board acquired a new stake in shares of Humana in the fourth quarter valued at approximately $1,517,000. Finally, California State Teachers Retirement System raised its position in shares of Humana by 39,982.9% in the second quarter. California State Teachers Retirement System now owns 68,644,780 shares of the insurance provider’s stock valued at $27,267,080,000 after buying an additional 68,473,523 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on HUM shares. Weiss Ratings upgraded Humana from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, August 14th. Zacks Research lowered Humana from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 11th. Needham & Company LLC assumed coverage on Humana in a report on Wednesday, May 20th. They issued a “buy” rating for the company. Guggenheim upped their target price on Humana from $269.00 to $471.00 and gave the company a “buy” rating in a research report on Thursday, July 30th. Finally, Robert W. Baird set a $390.00 target price on Humana in a report on Thursday, July 30th. Fourteen research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Humana has an average rating of “Hold” and a consensus target price of $403.91.

Read Our Latest Report on HUM

Humana Price Performance

Shares of HUM stock opened at $401.06 on Thursday. The business has a fifty day simple moving average of $388.61 and a 200 day simple moving average of $301.31. The company has a market cap of $48.16 billion, a P/E ratio of 37.94, a P/E/G ratio of 2.64 and a beta of 0.74. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $428.88.

Humana (NYSE:HUM – Get Free Report) last issued its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter in the previous year, the firm earned $6.27 earnings per share. The business’s quarterly revenue was up 26.2% on a year-over-year basis. On average, sell-side analysts forecast that Humana Inc. will post 9 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Friday, October 30th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, October 30th. This represents a $3.54 annualized dividend and a yield of 0.9%. Humana’s dividend payout ratio is presently 33.49%.

Humana Company Profile

(Free Report)

Humana Inc (NYSE:HUM) is a U.S.-based health insurance and health care services company focused primarily on government-sponsored programs. Its offerings include Medicare Advantage plans, Medicare prescription drug plans, Medicaid coverage and specialty insurance products, serving individuals, employers and government organizations.

Through its CenterWell business, Humana also provides senior-focused primary care, pharmacy services and home health care. These operations are designed to support coordinated care for older adults and other members with ongoing health care needs.

Humana was founded in 1961 as a nursing-home company and later expanded into hospital ownership before shifting its focus toward health insurance.